Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: Implications for economic analyses of phase III clinical trials
Charles L. Bennett, Stephen L. George, James O. Armitage, Julie M. Vose, John J. Nemunaitis, Jack L. Armitage, N. Claude Gorin, Subhash C. GulatiVolume:
13
Year:
1995
Language:
english
Pages:
7
DOI:
10.1002/stem.5530130412
File:
PDF, 560 KB
english, 1995